Singapore · Biotechnology

RVAC Medicines

RVAC Medicines is an mRNA platform company with a pipeline of novel products covering a wide range of disease areas.

PrivateFor profit

BiotechnologySingapore, Singapore

Against its peers

Set against 55 Biotechnology companies in Singapore. The ring marks the typical peer.

Staff51-100Larger than the typical peer (11-50)
Founded202110 years after the typical peer (2011)

Across all 5.9M companies: larger than 75% of those with a size listed; older than 0% of those with a founding year.

About RVAC Medicines

What it does

BiotechnologyMedicalProduct Research

Funding, as listed

What the source datasets report. We have not watched these rounds ourselves.

$140M

raised in total, currency not stated across 1 round

Last raised Apr 2022, 4 years ago

Rounds
1
Latest round
Series b
Investors
41 leading

Every detail we hold

Everything the source datasets list about RVAC Medicines, field by field. Contact details are held but never shown.

The company6 fields

Name
RVAC Medicines
Type
For profit
Status
Private
Founded
2021
Industry
Biotechnology
Categories
Biotechnology, Medical, Product Research

Where3 fields

City
Singapore
Country
Singapore
Markets
Asia-Pacific (APAC), Association of Southeast Asian Nations (ASEAN), Southeast Asia

Size and reach1 field

Staff band
51-100
Show 9 more fieldsShow fewer fields

Funding, as listed7 fields

Total
140,000,000 (currency not stated)
Rounds
1
Latest round
Series b
Latest round date
Apr 2022
Investors
4
Lead investors
1
Listing status
private

About this record2 fields

Sources
Crunchbase
Last imported
Sept 2026

Companies like RVAC Medicines

Biotechnology in Singapore.

Build a lead list

55 Biotechnology companies in Singapore, filtered by size, age and reach, ready to export with emails on Pro.

Open the list